Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3975 | 1795 | 43.2 | 79% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | IMMUNOGENE | Author keyword | 3 | 50% | 0% | 4 |
2 | MED MOLEC BIOL SHINJUKU KU | Address | 2 | 44% | 0% | 4 |
3 | ERBB PROTEINS | Author keyword | 2 | 67% | 0% | 2 |
4 | LIGAND INDUCED DIMERIZATION | Author keyword | 2 | 67% | 0% | 2 |
5 | TOXICOPATHOL | Address | 2 | 25% | 0% | 6 |
6 | CONFORMATION SPECIFIC ANTIBODY | Author keyword | 1 | 50% | 0% | 2 |
7 | EGF RECEPTOR GENE | Author keyword | 1 | 50% | 0% | 2 |
8 | MED HEMATOL ONCOL BIOL CHEM | Address | 1 | 100% | 0% | 2 |
9 | MOL DRUG DISCOVERY | Address | 1 | 50% | 0% | 2 |
10 | TYROSINE KINASE INHIBITOR PD153035 | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | IMMUNOGENE | 3 | 50% | 0% | 4 | Search IMMUNOGENE | Search IMMUNOGENE |
2 | ERBB PROTEINS | 2 | 67% | 0% | 2 | Search ERBB+PROTEINS | Search ERBB+PROTEINS |
3 | LIGAND INDUCED DIMERIZATION | 2 | 67% | 0% | 2 | Search LIGAND+INDUCED+DIMERIZATION | Search LIGAND+INDUCED+DIMERIZATION |
4 | CONFORMATION SPECIFIC ANTIBODY | 1 | 50% | 0% | 2 | Search CONFORMATION+SPECIFIC+ANTIBODY | Search CONFORMATION+SPECIFIC+ANTIBODY |
5 | EGF RECEPTOR GENE | 1 | 50% | 0% | 2 | Search EGF+RECEPTOR+GENE | Search EGF+RECEPTOR+GENE |
6 | TYROSINE KINASE INHIBITOR PD153035 | 1 | 100% | 0% | 2 | Search TYROSINE+KINASE+INHIBITOR+PD153035 | Search TYROSINE+KINASE+INHIBITOR+PD153035 |
7 | A431 CELL | 1 | 20% | 0% | 6 | Search A431+CELL | Search A431+CELL |
8 | A 431 CELLS | 1 | 33% | 0% | 2 | Search A+431+CELLS | Search A+431+CELLS |
9 | HUMAN GLIOBLASTOMA MULTIFORME | 1 | 33% | 0% | 2 | Search HUMAN+GLIOBLASTOMA+MULTIFORME | Search HUMAN+GLIOBLASTOMA+MULTIFORME |
10 | A23187 CALCIUM IONOPHORE | 1 | 50% | 0% | 1 | Search A23187+CALCIUM+IONOPHORE | Search A23187+CALCIUM+IONOPHORE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SELF PHOSPHORYLATION | 61 | 65% | 3% | 58 |
2 | A431 CELLS | 36 | 22% | 8% | 143 |
3 | LIGAND INDUCED INTERNALIZATION | 20 | 35% | 3% | 48 |
4 | POSTENDOCYTIC TRAFFICKING | 17 | 59% | 1% | 19 |
5 | AUTOPHOSPHORYLATION SITES | 12 | 18% | 3% | 60 |
6 | ENDOCYTIC SYSTEM | 12 | 63% | 1% | 12 |
7 | FACTOR EGF RECEPTOR | 10 | 28% | 2% | 32 |
8 | ERBB RECEPTORS | 10 | 12% | 4% | 74 |
9 | EXTRACELLULAR REGION | 9 | 26% | 2% | 29 |
10 | CARCINOMA CELLS A 431 | 7 | 44% | 1% | 12 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
SIGNAL TRANSDUCTION BY RECEPTORS WITH TYROSINE KINASE-ACTIVITY | 1990 | 4682 | 85 | 38% |
ENDOCYTOSIS OF GROWTH-FACTOR RECEPTORS | 1993 | 223 | 47 | 79% |
A Structural Perspective on the Regulation of the Epidermal Growth Factor Receptor | 2015 | 1 | 135 | 53% |
EGF receptor trafficking: consequences for signaling and cancer | 2014 | 35 | 109 | 27% |
Ligand-induced, receptor-mediated dimerization and activation of EGF receptor | 2002 | 508 | 17 | 53% |
EGF-ERBB signalling: towards the systems level | 2006 | 853 | 135 | 22% |
Endocytosis and intracellular trafficking of ErbBs | 2009 | 234 | 158 | 34% |
Ligand-induced ErbB receptor dimerization | 2009 | 84 | 91 | 67% |
The ErbB/HER family of protein-tyrosine kinases and cancer | 2014 | 55 | 278 | 12% |
Structure-based view of epidermal growth factor receptor regulation | 2008 | 92 | 72 | 54% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MED MOLEC BIOL SHINJUKU KU | 2 | 44% | 0.2% | 4 |
2 | TOXICOPATHOL | 2 | 25% | 0.3% | 6 |
3 | MED HEMATOL ONCOL BIOL CHEM | 1 | 100% | 0.1% | 2 |
4 | MOL DRUG DISCOVERY | 1 | 50% | 0.1% | 2 |
5 | CELLULAR ST S PONSES | 1 | 30% | 0.2% | 3 |
6 | MARRY BABB RANDOLPH CANC | 1 | 40% | 0.1% | 2 |
7 | MED MOLEC BIOL35 SHINANOMACHI | 1 | 40% | 0.1% | 2 |
8 | PROTE SCI | 1 | 40% | 0.1% | 2 |
9 | INFORMAT PROC BIOL UNIT | 1 | 33% | 0.1% | 2 |
10 | BIO REMODELING GENE THER Y | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000191564 | BREAST CARCINOMA CELL LINE//BIOTINYLATED EPIDERMAL GROWTH FACTOR//BREAST CANCER BIOPSIES |
2 | 0.0000166732 | TRANSFORMING GROWTH FACTOR ALPHA//TGF ALPHA//HTGF ALPHA |
3 | 0.0000153027 | HER3//NUCLEAR EGFR//EGFR FAMILY |
4 | 0.0000142095 | V ERB B//V ERBB//ACUTE RETROVIRUS |
5 | 0.0000114233 | MED OBSTET GYNECOL1150 FUKUSHIMA//MED RALPH L SMITH PHYSIOL//ADV TECHNOL PLICAT ILTEK |
6 | 0.0000112728 | EGF POLYMORPHISM//GEFITINIB THERAPY//INTRON 1 POLYMORPHISM |
7 | 0.0000103241 | SWISS 3T3 CELL//E5050//FREE CALCIUM ION |
8 | 0.0000100984 | C ERBB 2//HER 2 NEU//P185 |
9 | 0.0000095070 | NIMOTUZUMAB//H R3//CETUXIMAB |
10 | 0.0000093594 | S 1 2 DICARBOXYETHYLGLUTATHIONE//ALPHA2 ADRENERGIC RESPONSE//BIOCHEM PHARMACOL GRP |